Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial

NCT02995083 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study deemed not feasible

Conditions

Symptomatic Osteoarthritis of the Knee

Interventions

DRUG: 40 mg Depo-Medrol in 1 ml, 9 ml of 1% lidocaine
DRUG: Normal Saline 10 ml
DRUG: Air 10 ml

Sponsor

Rush University Medical Center